Veteran Pharma Insider Buys: Biotech Stock Momentum Explored
A seasoned pharma investor places a sizable bet on Nuvation Bio as a promising drug moves forward. Learn how insider ...
Examines historic SP 500 downturns affecting retirees, highlighting lessons for risk management and smarter, longer-term retirement strategies.
28,655 articlesA seasoned pharma investor places a sizable bet on Nuvation Bio as a promising drug moves forward. Learn how insider ...
A veteran macro strategist says the classic college route may not pay off for today’s youth. He points to skilled tra...
Biotech investing offers life-changing upside, but it also comes with steep risks. This guide breaks down whether cou...
February brought a sharp drop for Upstart as investors weighed margins, product risk, and leadership changes. This de...
Strategy led by Michael Saylor sold a record 3,588 BTC for $216 million, sparking debate about Bitcoin's direction. A...
TAO jumps more than 10% in a single session as Bitcoin targets $72,000. The move sets the tone for a weekend of volat...
Jim Cramer argues that South Korea mispricing SK Hynix reflects trader psychology rather than weak fundamentals. He r...
Patience and a long time horizon are the most powerful tools in any investor’s kit. This guide explains why waiting f...
RLJ Lodging Trust has fallen about 8% over the last 12 months. Yet a sizeable stake by a key investor suggests there ...
A once-hot cybersecurity stock has fallen 40%, yet a large investor just increased exposure. This guide breaks down w...
Investors watched spacemobile stock crushed thursday move sharply as AT&T, Verizon, and T-Mobile signaled a bold sate...
As Warren Buffett steps back, Greg Abel’s potential move to buy a stock Buffett loves has investors buzzing. This art...